Nano-X Imaging (NNOX) Gains from Investment Securities (2024 - 2025)

Nano-X Imaging (NNOX) posted quarterly Gains from Investment Securities of $136000.0 for Q4 2025, up 58.14% year-on-year from $86000.0 in Q4 2024, and up 58.14% on a QoQ basis from $86000.0 in Q4 2024.

Nano-X Imaging (NNOX) Gains from Investment Securities (2024 - 2025) Analysis & Trends

Nano-X Imaging (NNOX) has reported Gains from Investment Securities for 2 consecutive years, with $136000.0 the latest figure, recorded in Q4 2025.

  • Quarterly Gains from Investment Securities rose 58.14% year-over-year to $136000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $167000.0 (down 17.33% YoY) and the FY2025 annual result came in at $207000.0, up 2.48% from the prior year.
  • Gains from Investment Securities climbed to $136000.0 in Q4 2025 per NNOX's latest filing, from $86000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for NNOX reached as high as $146000.0 in Q2 2024 and fell as low as -$55000.0 in Q3 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 Nano-X Imaging 62,810.26 -44.16 Mn -2.59 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 136,000.00
Dec 31, 2025 136,000.00
Dec 31, 2024 86,000.00
Dec 31, 2024 86,000.00
Sep 30, 2024 -55,000.00
Sep 30, 2024 -55,000.00
Jun 30, 2024 146,000.00
Jun 30, 2024 146,000.00
Mar 31, 2024 25,000.00
Mar 31, 2024 25,000.00